Less Vigorous Surgery for Second Primary Lung Cancer

Abstract

Background: Patients with second primary lung cancer (SPLC) have a heterogeneous background. The optimum modality of treatment for SPLC patients has not yet been determined. The objective of this study was to attempt to identify the value of less vigorous therapies such as segmentectomy or video-assisted thoracic surgery (VATS) in SPLC. Methods: We retrospectively reviewed the medical records of 46 patients who underwent resection for SPLC in Fukuoka University Hospital between January 1994 and April 2005. Patients were separated into two groups (LVT: less vigorous therapy including segmentectomy or VATS lobectomy; LCT: lobectomy with conventional thoracotomy). The characteristics of each group were evaluated and survival rates were analyzed at 5 years after surgery. Results: The mean amount of blood loss was found to be significantly different (p = 0.0062) with 59.44 ± 14.00 ml for LVT cases and 254.48 ± 63.62 ml for LCT. None of the LVT patients experienced postoperative complications. The 5-year survival rate was 62.7 % for LVT and 57.7 % for LCT. There was no significant difference in survival rates between these groups. Conclusions: Although differences were seen in the characteristics, less invasive surgery such as VATS or segmentectomy may be a feasible treatment for SPLC.

Second primary lung cancer - less vigorous therapy - VATS - segmentectomy

References

• 1 Keller S M, Vangel M G, Wagner H, Schiller J, Herskovic A, Komaki R, Gray R, Marks R S, Perry M C, Livingston R B, Johnson D H. Eastern Cooperative Oncology Group . Second primary tumors following adjuvant therapy of resected stages II and IIIa non small cell lung cancer.  Lung Cancer. 2003;  42 79-86
• 2 Rice D, Kim H W, Sabichi A, Lippman S, Lee J J, Williams B, Vaporciyan A, Smythe W R, Swisher S, Walsh G, Putnam Jr J B, Hong W K, Roth J. The risk of second primary tumors after resection of stage I non-small cell lung cancer.  Ann Thorac Surg. 2003;  76 1001-1007
• 3 Teppo L, Salminen E, Pukkala E. Risk of a new primary cancer among patients with lung cancer of different histological types.  Eur J Cancer. 2001;  37 613-619
• 4 Ribet M, Dambron P. Multiple primary lung cancers.  Eur J Cardiothorac Surg. 1995;  9 231-236
• 5 Daniels L J, Balderson S S, Mark P A‐C, Onaitis M W, D'Amico T A. Thoracoscopic lobectomy: A safe and effective strategy for patients with stage I lung cancer.  Ann Thorac Surg. 2002;  74 860-864
• 6 Bando T, Yamagihara Y, Ohtake Y, Miyahara R, Tanaka F, Hasegawa S, Inui K, Wada H. A new method of segmental resection for primary lung cancer: intermediate results.  Eur J Cardiothorac Surg. 2002;  21 894-899
• 7 Faber L P. Resection for second and third primary lung cancer.  Semi Surg Oncol. 1993;  9 135-141
• 8 Lundehard G, Hansson L E, Nyren O. The risk of gastrointestinal and other primary malignant disease following gastric cancer.  Acta Oncol. 1991;  30 1-6
• 9 Thomas P, Doddoli C, Yena S, Thirion X, Sebag F, Fuentes P, Giudicelli R. VATS is adequate oncological operation for stage I non-small cell lung cancer.  Eur J Cardiothorac Surg. 2002;  21 1094-1099
• 10 Iwasaki A, Shirakusa T, Shiraishi T, Yamamoto S. Results of video-assisted thoracic surgery for stage I/II non small cell lung cancer.  Eur J Cardiovasc Surg. 2004;  26 158-164
• 11 Yoshikawa K, Tsubota N, Kodama K, Ayabe H, Taki T, Mori T the study group of extended segmentectomy for small lung tumors for . Prospective study of extended segmentectomy for small lung tumors: the final report.  Ann Thorac Surg. 2002;  73 1055-1059
• 12 Voltolini L, Paladini P, Luzzi L, Chiribelli C, Bisceglie M D, Gotti G. Iterative surgical resection for local recurrence and second primary bronchogenic carcinoma.  Eur J Cardiovasc Surg. 2000;  18 529-534
• 13 Aziz T M, Saad R A, Glasser J, Jilaihawi A N, Prakash D. The management of second primary lung cancers. A single centre experience in 15 years.  Eur J Cardiothorac Surg. 2002;  21 527-533
• 14 Iwasaki A, Shirakusa T, Kawahara K, Yoshinaga Y, Okabayashi K, Shiraishi T. Is video-assisted thoracoscopic surgery suitable for resection of primary lung cancer?.  Thorac Cardiovasc Surgeon. 1997;  45 13-15